Stock Updates

Today’s Top Gainers in the Market IDEXX Laboratories, Inc. (NASDAQ:IDXX) from Healthcare

Today’s top gainers include the company IDEXX Laboratories, Inc. (NASDAQ:IDXX) which is in the industry Diagnostic Substances, gaining 1.49% today. In the last week its performance is 3.47%, and 24.22% for the past quarter. Currently, IDEXX Laboratories, Inc., IDXX has a target price of 116.8, so today’s gain of 1.49% is a significant step towards its target price. The GAP today is therefore 0.13%.

IDEXX Laboratories, Inc. (NASDAQ:IDXX), has a market cap of 10513, and is based in USA. Insider ownership is at 1.30%, and institutional ownership is 94.90%.

At the current price of 117.04, it has a dividend yield of *TBA, and its target price is 116.8. This is with a profit margin of 11.90%, and total debt/equity of *TBA. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has a P/E of 52.98, as well as a forward P/E of 43.46.

With a current EPS of 2.21, and a forecasted EPS growth for next year at 14.06%,IDEXX Laboratories, Inc. (NASDAQ:IDXX) has had a EPS growth for the past five years at 11.60%. For the next five years EPS growth is projected to be 14.35%.

Performance for the year is 58.06%. Since its IPO date on 6/24/1991, the total performance to date is 60.50%.

Volume today for IDEXX Laboratories, Inc. (NASDAQ:IDXX), is 270900, while its average volume is 489.51. Whilst the total gain today was 1.49%, it did have a day high of 1.32%.

Volatility for this week has been at 1.63%, and 1.64% for the month. The 52-week low for IDEXX Laboratories, Inc., IDXX has been 84.37%, while the 52-week-high has reached 1.32%.

Looking at its return of investments, which is 22.10%, and its return on assets is 13.60%. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has an operating margin of 18.70%. With a sales growth of 12.90% quarter over quarter. Bearing in mind that IDEXX Laboratories, Inc., IDXX is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of 1 and 0.8 for quick ratio.

So what is the value of IDEXX Laboratories, Inc.? Well its PEG is 3.69, and the P/S is 6.22, along with a P/B of *TBA. Meanwhile it has a p/cash of 28.4.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment